Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Green tea extract and cycling hormone treatments may help treat advanced prostate cancer.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Skin reactions from cancer treatments might predict how well the treatments work.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

A new system was created to classify skin changes in cancer patients based on their treatment.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Microagulhamento e intradermoterapia juntos melhoram o crescimento capilar em mulheres menopausadas.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.